Grand Rounds February 24, 2023: S2302 Pragmatica-Lung: New Directions for Decreasing Burden and Increasing Inclusion in NCTN Clinical Trials (Konstantin Dragnev, MD; Karen Reckamp, MD, MS)
Rethinking Clinical Trials
MARCH 1, 2023
When we started working on this the discussions with NCI and FDA were about stripping away eligibility, we realized the population would be less controlled than previous studies. We kept coming back to the one thing we want to know, which is the overall survival.
Let's personalize your content